These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 24522637)
1. A sensitive two-photon probe to selectively detect monoamine oxidase B activity in Parkinson's disease models. Li L; Zhang CW; Chen GY; Zhu B; Chai C; Xu QH; Tan EK; Zhu Q; Lim KL; Yao SQ Nat Commun; 2014; 5():3276. PubMed ID: 24522637 [TBL] [Abstract][Full Text] [Related]
2. A Small-Molecule Probe for Selective Profiling and Imaging of Monoamine Oxidase B Activities in Models of Parkinson's Disease. Li L; Zhang CW; Ge J; Qian L; Chai BH; Zhu Q; Lee JS; Lim KL; Yao SQ Angew Chem Int Ed Engl; 2015 Sep; 54(37):10821-5. PubMed ID: 26205378 [TBL] [Abstract][Full Text] [Related]
3. A Strategy for Specific Fluorescence Imaging of Monoamine Oxidase A in Living Cells. Wu X; Shi W; Li X; Ma H Angew Chem Int Ed Engl; 2017 Nov; 56(48):15319-15323. PubMed ID: 29027345 [TBL] [Abstract][Full Text] [Related]
4. Sensitive and Selective Ratiometric Fluorescence Probes for Detection of Intracellular Endogenous Monoamine Oxidase A. Wu X; Li L; Shi W; Gong Q; Li X; Ma H Anal Chem; 2016 Jan; 88(2):1440-6. PubMed ID: 26652905 [TBL] [Abstract][Full Text] [Related]
5. Oxazolopyridines and thiazolopyridines as monoamine oxidase B inhibitors for the treatment of Parkinson's disease. Park HR; Kim J; Kim T; Jo S; Yeom M; Moon B; Choo IH; Lee J; Lim EJ; Park KD; Min SJ; Nam G; Keum G; Lee CJ; Choo H Bioorg Med Chem; 2013 Sep; 21(17):5480-7. PubMed ID: 23810676 [TBL] [Abstract][Full Text] [Related]
6. Association of a monoamine oxidase B allele with Parkinson's disease. Kurth JH; Kurth MC; Poduslo SE; Schwankhaus JD Ann Neurol; 1993 Apr; 33(4):368-72. PubMed ID: 8489207 [TBL] [Abstract][Full Text] [Related]
7. Novel MAO-B inhibitors: potential therapeutic use of the selective MAO-B inhibitor PF9601N in Parkinson's disease. Unzeta M; Sanz E Int Rev Neurobiol; 2011; 100():217-36. PubMed ID: 21971010 [TBL] [Abstract][Full Text] [Related]
8. Reversible and irreversible small molecule inhibitors of monoamine oxidase B (MAO-B) investigated by biophysical techniques. Rojas RJ; Edmondson DE; Almos T; Scott R; Massari ME Bioorg Med Chem; 2015 Feb; 23(4):770-8. PubMed ID: 25600407 [TBL] [Abstract][Full Text] [Related]
9. Inhibition of monoamine oxidase by selected C6-substituted chromone derivatives. Legoabe LJ; Petzer A; Petzer JP Eur J Med Chem; 2012 Mar; 49():343-53. PubMed ID: 22309913 [TBL] [Abstract][Full Text] [Related]
10. The EcoRV genetic polymorphism of human monoamine oxidase type A is not associated with Parkinson's disease and does not modify the effect of smoking on Parkinson's disease. Costa-Mallen P; Checkoway H; Fishel M; Cohen AW; Smith-Weller T; Franklin GM; Swanson PD; Costa LG Neurosci Lett; 2000 Jan; 278(1-2):33-6. PubMed ID: 10643794 [TBL] [Abstract][Full Text] [Related]
11. Novel bifunctional drugs targeting monoamine oxidase inhibition and iron chelation as an approach to neuroprotection in Parkinson's disease and other neurodegenerative diseases. Youdim MB; Fridkin M; Zheng H J Neural Transm (Vienna); 2004 Oct; 111(10-11):1455-71. PubMed ID: 15480846 [TBL] [Abstract][Full Text] [Related]
12. Inhibition of monoamine oxidase by indole and benzofuran derivatives. Prins LH; Petzer JP; Malan SF Eur J Med Chem; 2010 Oct; 45(10):4458-66. PubMed ID: 20674099 [TBL] [Abstract][Full Text] [Related]
13. Ratiometric Near-Infrared Fluorescent Probe for Synergistic Detection of Monoamine Oxidase B and Its Contribution to Oxidative Stress in Cell and Mice Aging Models. Wang R; Han X; You J; Yu F; Chen L Anal Chem; 2018 Mar; 90(6):4054-4061. PubMed ID: 29400049 [TBL] [Abstract][Full Text] [Related]
14. Pharmacologic treatment of advanced Parkinson's disease: a meta-analysis of COMT inhibitors and MAO-B inhibitors. Talati R; Reinhart K; Baker W; White CM; Coleman CI Parkinsonism Relat Disord; 2009 Aug; 15(7):500-5. PubMed ID: 19167259 [TBL] [Abstract][Full Text] [Related]
15. SL25.1131 [3(S),3a(S)-3-methoxymethyl-7-[4,4,4-trifluorobutoxy]-3,3a,4,5-tetrahydro-1,3-oxazolo[3,4-a]quinolin-1-one], a new, reversible, and mixed inhibitor of monoamine oxidase-A and monoamine oxidase-B: biochemical and behavioral profile. Aubin N; Barneoud P; Carter C; Caille D; Sontag N; Marc C; Lolivier J; Gardes A; Perron C; Le Kim A; Charieras T; Pandini M; Burnier P; Puech F; Jegham S; George P; Scatton B; Curet O J Pharmacol Exp Ther; 2004 Sep; 310(3):1171-82. PubMed ID: 15178694 [TBL] [Abstract][Full Text] [Related]
16. Multiscale Modeling of Two-Photon Probes for Parkinson's Diagnostics Based on Monoamine Oxidase B Biomarker. Murugan NA; Zaleśny R J Chem Inf Model; 2020 Aug; 60(8):3854-3863. PubMed ID: 32786232 [TBL] [Abstract][Full Text] [Related]
17. Design of chemical shift-switching 19F magnetic resonance imaging probe for specific detection of human monoamine oxidase A. Yamaguchi K; Ueki R; Nonaka H; Sugihara F; Matsuda T; Sando S J Am Chem Soc; 2011 Sep; 133(36):14208-11. PubMed ID: 21851116 [TBL] [Abstract][Full Text] [Related]
18. Genetic polymorphism of monoamine oxidase B and susceptibility of Parkinson's disease. Hwang WJ; Lai ML; Tsai TT; Lai MD Zhonghua Yi Xue Za Zhi (Taipei); 1997 Sep; 60(3):137-41. PubMed ID: 9419949 [TBL] [Abstract][Full Text] [Related]
19. Neuroprotective profile of the multitarget drug rasagiline in Parkinson's disease. Weinreb O; Amit T; Riederer P; Youdim MB; Mandel SA Int Rev Neurobiol; 2011; 100():127-49. PubMed ID: 21971006 [TBL] [Abstract][Full Text] [Related]
20. An activity-based fluorogenic probe for sensitive and selective monoamine oxidase-B detection. Long S; Chen L; Xiang Y; Song M; Zheng Y; Zhu Q Chem Commun (Camb); 2012 Jul; 48(57):7164-6. PubMed ID: 22692558 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]